NewGenIVF Group Limited (Nasdaq: NIVF) said its 13% stake in K25.ai is now valued at approximately $26 million, based on an implied valuation of $200 million established through K25.ai's recently closed Series A investment round, according to a company statement.

The Bangkok-based company said the stake, which remains subject to completion of share purchase agreements, represents an expected unrealized gain of approximately $8.5 million. NewGen initially acquired the interest at a lower implied valuation.

NewGen reported net profit attributable to shareholders of $9.9 million for the fiscal year ended December 31, 2025, with net assets of approximately $25.98 million as of that date.

Following the issuance of 2,500,000 Class A ordinary shares announced on July 27, 2026, the company's total outstanding Class A ordinary share count is expected to reach approximately 5.9 million.

Alfred Siu, Founder, Chairman and CEO, said: "The step-up in K25.ai's implied valuation to $200 million brings our 13% stake to approximately $26 million and generates an expected unrealized gain of approximately $8.5 million, further strengthening our balance sheet as we execute on our growth strategy."

NewGen operates across real estate development, digital assets, and reproductive health services.